Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.

Arthritis Res Ther · 2018 · PMC6235221 · PMID 30285841

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

did not reach statistical significancep = 0.066so close (0.05 < p ≤ 0.1)

Relapse rate was also higher in patients showing an increased memory B cell/CD19 + B cell ratio after treatment, but this association did not reach statistical significance (HR, 3.73; 0.91 to 15.24; p = 0.066) (Fig. 3b ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.